RxDoctor Payments Data

Daniel Perkins, MD

Family Medicine · Madison, FLNPI 1124087556

Payments from drug & device makers

$1,077in general payments, 2019–2025

Across 68 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$149
  • Novo Nordisk$129
  • Lilly USA, LLC$118
  • Bayer$88
  • Novartis$86
  • AstraZeneca$68
  • plus $439 from 19 others

What the payments were for

  • Food & beverage$1,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,077 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$67,054
Medicare patients
252
Services billed
944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban177$55,190
TrulicityDulaglutide37$52,595
JardianceEmpagliflozin81$36,363
OzempicSemaglutide17$23,695
FarxigaDapagliflozin Propanediol39$19,679
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen501$14,618
JanuviaSitagliptin Phosphate31$13,982
AbrysvoRsv Vacc, Pref A And Pref B/Pf33$10,320
MultaqDronedarone Hcl22$8,745
XareltoRivaroxaban28$8,687
LinzessLinaclotide12$7,788
MyrbetriqMirabegron18$5,250
Trazodone Hcl328$5,025
MovantikNaloxegol Oxalate23$4,722
Potassium Chloride171$4,681

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$14$65,510210 claims
Lilly USA, LLCTrulicity$118$52,59537 claims
Boehringer IngelheimJardiance$18$36,36381 claims
Novo NordiskOzempic$129$23,69517 claims
AstraZenecaFarxiga$68$19,67939 claims
MerckJanuvia$14$13,98231 claims
AbbVieLinzess, Lumigan$149$10,73823 claims
Johnson & JohnsonXarelto$45$8,68728 claims
Astellas Pharma US IncMyrbetriq$19$5,25018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Madison

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →